{"abstract":"The Food and Drug Administration's (FDA) Center for Drug Evaluation and Research (CDER) is announcing a Novel Excipient Review Pilot Program (Pilot Program). The Pilot Program is voluntary and intended to allow excipient manufacturers to obtain FDA review of certain novel excipients prior to their use in drug formulations. The Pilot Program seeks to foster development of excipients that may be useful in scenarios in which excipient manufacturers and drug developers have cited difficulty in using existing excipients.","action":"Notice.","agencies":[{"raw_name":"DEPARTMENT OF HEALTH AND HUMAN SERVICES","name":"Health and Human Services Department","id":221,"url":"https://www.federalregister.gov/agencies/health-and-human-services-department","json_url":"https://www.federalregister.gov/api/v1/agencies/221","parent_id":null,"slug":"health-and-human-services-department"},{"raw_name":"Food and Drug Administration","name":"Food and Drug Administration","id":199,"url":"https://www.federalregister.gov/agencies/food-and-drug-administration","json_url":"https://www.federalregister.gov/api/v1/agencies/199","parent_id":221,"slug":"food-and-drug-administration"}],"body_html_url":"https://www.federalregister.gov/documents/full_text/html/2021/09/08/2021-19335.html","cfr_references":[],"citation":"86 FR 50363","comment_url":null,"comments_close_on":null,"correction_of":null,"corrections":[],"dates":"FDA is seeking initial proposals for the voluntary Novel Excipient Review Pilot Program through December 7, 2021.","disposition_notes":null,"docket_ids":["Docket No. FDA-2019-N-5464"],"dockets":[],"document_number":"2021-19335","effective_on":null,"end_page":50365,"executive_order_notes":null,"executive_order_number":null,"full_text_xml_url":"https://www.federalregister.gov/documents/full_text/xml/2021/09/08/2021-19335.xml","html_url":"https://www.federalregister.gov/documents/2021/09/08/2021-19335/center-for-drug-evaluation-and-research-office-of-new-drugs-novel-excipient-review-pilot-program","images":{},"images_metadata":{},"json_url":"https://www.federalregister.gov/api/v1/documents/2021-19335?publication_date=2021-09-08","mods_url":"https://www.govinfo.gov/metadata/granule/FR-2021-09-08/2021-19335/mods.xml","not_received_for_publication":null,"page_length":3,"page_views":{"count":1466,"last_updated":"2026-11-22 06:15:04 -0500"},"pdf_url":"https://www.govinfo.gov/content/pkg/FR-2021-09-08/pdf/2021-19335.pdf","presidential_document_number":null,"proclamation_number":null,"public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2021-19335.pdf?1631018730","publication_date":"2021-09-08","raw_text_url":"https://www.federalregister.gov/documents/full_text/text/2021/09/08/2021-19335.txt","regulation_id_number_info":{},"regulation_id_numbers":[],"regulations_dot_gov_info":{"supporting_documents":[],"comments_count":1,"agency_id":"FDA","comments_url":"https://www.regulations.gov/docketBrowser?rpp=50&so=DESC&sb=postedDate&po=0&dct=PS&D=FDA-2019-N-5464","supporting_documents_count":0,"docket_id":"FDA-2019-N-5464","document_id":"FDA-2019-N-5464-0028","regulation_id_number":null,"title":"Novel Excipient Review Program Proposal; Request for Information and Comments","checked_regulationsdotgov_at":"2021-12-08T06:18:54Z"},"regulations_dot_gov_url":null,"significant":null,"signing_date":null,"start_page":50363,"subtype":null,"title":"Center for Drug Evaluation and Research Office of New Drugs Novel Excipient Review Pilot Program","toc_doc":"Center for Drug Evaluation and Research Office of New Drugs Novel Excipient Review Pilot Program","toc_subject":null,"topics":[],"type":"Notice","volume":86}